• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCK-B/胃泌素受体拮抗剂在奥美拉唑治疗期间对胃蛋白酶原产生细胞的影响。

Effect of CCK-B/gastrin receptor antagonist on pepsinogen-producing cells during omeprazole treatment.

作者信息

Kakei N, Ichinose M, Tatematsu M, Shimizu M, Ishihama S, Yahagi N, Matsushima M, Fukamachi H, Miki K, Kurokawa K

机构信息

First Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

出版信息

Biochem Biophys Res Commun. 1995 May 16;210(2):400-8. doi: 10.1006/bbrc.1995.1675.

DOI:10.1006/bbrc.1995.1675
PMID:7626146
Abstract

The present study investigated the effect of long-term treatment with omeprazole on pepsinogen-producing cells and examined whether the selective CCK-B/gastrin receptor antagonist was able to prevent the omeprazole-induced changes, if occurred, in rat stomach. Rats were treated with omeprazole and/or the CCK-B/gastrin receptor antagonist for 28 days. As a result, omeprazole markedly reduced mucosal pepsinogen activity and its mRNA concentration in rat stomach. Morphologically, in fundic glands omeprazole drastically decreased the proportion of mature chief cells and reciprocally increased that of immature chief cells which were positive for class III mucin. These effects of omeprazole were attenuated by an addition of the CCK-B/gastrin receptor antagonist. Our results suggest that omeprazole retards the differentiation of chief cells in fundic mucosa probably through hypergastrinemia in adult rat.

摘要

本研究调查了长期使用奥美拉唑治疗对胃蛋白酶原产生细胞的影响,并检测了选择性CCK - B/胃泌素受体拮抗剂是否能够预防奥美拉唑引起的(如果发生的话)大鼠胃的变化。大鼠用奥美拉唑和/或CCK - B/胃泌素受体拮抗剂治疗28天。结果显示,奥美拉唑显著降低了大鼠胃黏膜中的胃蛋白酶原活性及其mRNA浓度。形态学上,在胃底腺中,奥美拉唑大幅降低了成熟主细胞的比例,相应地增加了对III类粘蛋白呈阳性的未成熟主细胞的比例。添加CCK - B/胃泌素受体拮抗剂可减弱奥美拉唑的这些作用。我们的结果表明,在成年大鼠中,奥美拉唑可能通过高胃泌素血症延缓胃底黏膜主细胞的分化。

相似文献

1
Effect of CCK-B/gastrin receptor antagonist on pepsinogen-producing cells during omeprazole treatment.CCK-B/胃泌素受体拮抗剂在奥美拉唑治疗期间对胃蛋白酶原产生细胞的影响。
Biochem Biophys Res Commun. 1995 May 16;210(2):400-8. doi: 10.1006/bbrc.1995.1675.
2
Effects of omeprazole on gastric mucosal growth and differentiation in developing rat.奥美拉唑对发育中大鼠胃黏膜生长和分化的影响。
Biochem Biophys Res Commun. 1993 Nov 30;197(1):310-8. doi: 10.1006/bbrc.1993.2477.
3
Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.胆囊收缩素B/胃泌素受体阻断后大鼠胃肠嗜铬样细胞失活的时间进程。
Br J Pharmacol. 1997 Sep;122(1):1-6. doi: 10.1038/sj.bjp.0701316.
4
Omeprazole, a proton pump inhibitor, reduces the secretion, synthesis and gene expression of pepsinogen in the rat stomach.
Biochem Biophys Res Commun. 1993 Sep 15;195(2):997-1004. doi: 10.1006/bbrc.1993.2143.
5
Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.胃泌素/缩胆囊素B受体拮抗剂S-0509对奥美拉唑诱导的大鼠胃黏膜增殖的影响。
J Lab Clin Med. 2003 Dec;142(6):364-71. doi: 10.1016/S0022-2143(03)00151-3.
6
Effects of long-term omeprazole treatment on adult rat gastric mucosa--enhancement of the epithelial cell proliferation and suppression of its differentiation.长期奥美拉唑治疗对成年大鼠胃黏膜的影响——增强上皮细胞增殖并抑制其分化。
Biochem Biophys Res Commun. 1995 Sep 25;214(3):861-8. doi: 10.1006/bbrc.1995.2366.
7
Cholecystokinin-B/gastrin receptors enhance wound healing in the rat gastric mucosa.胆囊收缩素B/胃泌素受体可促进大鼠胃黏膜的伤口愈合。
J Clin Invest. 2000 Oct;106(8):1021-9. doi: 10.1172/JCI8115.
8
Role of gastrin/CCK-B receptor in the regulation of gastric acid secretion in rat.胃泌素/缩胆囊素B受体在大鼠胃酸分泌调节中的作用
Dig Dis Sci. 1997 Sep;42(9):1901-7. doi: 10.1023/a:1018863227013.
9
Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.CCK-A受体和CCK-B/胃泌素受体均可介导豚鼠胃腺中胃蛋白酶原的释放。
Am J Physiol. 1992 Jun;262(6 Pt 1):G1113-20. doi: 10.1152/ajpgi.1992.262.6.G1113.
10
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.YM022 [(R)-1-[2,3-二氢-1-(2'-甲基苯甲酰)-2-氧代-5-苯基-1H-1,4-苯并二氮杂卓-3-基]-3-(3-甲基苯基)脲],一种强效且选择性的胃泌素/胆囊收缩素-B受体拮抗剂,可预防大鼠的胃和十二指肠损伤。
J Pharmacol Exp Ther. 1994 Sep;270(3):1256-61.